BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

  April 21, 2026

   · 

  9 min read
• Press Releases

  Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva®

  April 21, 2026

   · 

  8 min read
• Press Releases

  Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

  April 21, 2026

   · 

  5 min read
• Press Releases

  Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion

  April 21, 2026

   · 

  3 min read
• Press Releases

  Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

  April 21, 2026

   · 

  6 min read
• Press Releases

  Modulari-T Biosciences Names Tanya E. Borsuk, PhD, as Chief Executive Officer

  April 21, 2026

   · 

  3 min read
• Press Releases

  Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

  April 21, 2026

   · 

  7 min read
• Press Releases

  Charles River Highlights Effectiveness of VCGs in Toxicology

  April 21, 2026

   · 

  5 min read
• Press Releases

  Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments

  April 21, 2026

   · 

  3 min read
• Press Releases

  Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

  April 21, 2026

   · 

  3 min read